Boydell, E.; Marinari, E.; Migliorini, D.; Dietrich, P.-Y.; Patrikidou, A.; Dutoit, V.
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients. Cancers 2019, 11, 464.
https://doi.org/10.3390/cancers11040464
AMA Style
Boydell E, Marinari E, Migliorini D, Dietrich P-Y, Patrikidou A, Dutoit V.
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients. Cancers. 2019; 11(4):464.
https://doi.org/10.3390/cancers11040464
Chicago/Turabian Style
Boydell, Emma, Eliana Marinari, Denis Migliorini, Pierre-Yves Dietrich, Anna Patrikidou, and Valérie Dutoit.
2019. "Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients" Cancers 11, no. 4: 464.
https://doi.org/10.3390/cancers11040464
APA Style
Boydell, E., Marinari, E., Migliorini, D., Dietrich, P. -Y., Patrikidou, A., & Dutoit, V.
(2019). Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients. Cancers, 11(4), 464.
https://doi.org/10.3390/cancers11040464